| Source: |
| Type: |
| Normal cells grow and divide in a regulated manner through the cell cycle, which consists of phases (G1, S, G2, and M). Cancer cells often bypass these regulatory mechanisms, leading to uncontrolled proliferation. This can result from mutations in genes that control the cell cycle, such as oncogenes (which promote cell division) and tumor suppressor genes (which inhibit cell division). |
| 8569- | Matr, | Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway |
| - | vitro+vivo, | Cerv, | NA |
| 8570- | Matr, | Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
| 8574- | Matr, | Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration |
| - | in-vitro, | Lung, | A549 | - | ex-vivo, | HCC, | SMMC-7721 cell |
| 8542- | Matr, | Matrine Suppresses Lung Cancer Progression via Dual Inhibition of CHEK1-Mediated DNA Damage Repair and PI3K/AKT Survival Signaling |
| - | vitro+vivo, | Lung, | A549 |
| 8537- | Matr, | Matrine restrains the development of colorectal cancer through regulating the AGRN/Wnt/β-catenin pathway |
| - | vitro+vivo, | CRC, | NA |
| 8535- | Matr, | Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel |
| - | in-vitro, | Cerv, | NA |
| 8558- | Matr, | Matrine exerts anti‑breast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF‑7 cells |
| - | in-vitro, | BC, | MCF7 |
| 8628- | MBZ, | Mebendazole induces apoptosis and inhibits migration via the reactive oxygen species-mediated STAT3 signaling downregulation in non-small cell lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 8629- | MBZ, | Repurposing the antihelmintic mebendazole as a hedgehog inhibitor |
| - | in-vitro, | Nor, | NIH-3T3 | - | vitro+vivo, | GBM, | GL-15 | - | in-vitro, | GC, | DAOY |
| 8635- | MBZ, | The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma |
| - | vitro+vivo, | Melanoma, | NA |
| 8636- | MBZ, | Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer |
| - | in-vivo, | Ovarian, | SKOV3 |
| 8655- | MBZ, | Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells |
| - | in-vitro, | Melanoma, | NA |
| 8648- | MBZ, | Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature |
| - | Review, | Var, | NA |
| 2500- | MBZ, | Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme |
| - | in-vitro, | GBM, | U87MG | - | in-vivo, | GBM, | NA |
| 2488- | mCHEMO, | Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma |
| - | in-vitro, | HCC, | HUH7 | - | in-vivo, | HCC, | NA |
| 8784- | mCHEMO, | Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells |
| - | Review, | Var, | NA |
| 8816- | MCP, | Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 |
| 8812- | MCP, | Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging |
| - | vitro+vivo, | Ovarian, | SKOV3 | - | in-vitro, | GC, | MKN-28 | - | in-vitro, | BC, | 4T1 |
| 8822- | MCP, | Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3 |
| - | vitro+vivo, | CRC, | T24/HTB-9 | - | in-vitro, | Bladder, | J82 |
| 8622- | MCT, | Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model |
| - | vitro+vivo, | HCC, | NA |
| 8715- | MeJa, | Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells |
| - | in-vitro, | BC, | MDA-MB-453 | - | in-vitro, | BC, | MCF-10AT |
| 8751- | MeSA, | PacT, | Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 8753- | MeSA, | Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis |
| - | vitro+vivo, | GBM, | U251 | - | in-vitro, | GBM, | U87MG |
| 8755- | MeSA, | The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice |
| - | in-vivo, | CRC, | NA |
| 8749- | MeSA, | etoposide, | Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo |
| - | in-vivo, | Pca, | NA |
| 8748- | MeSA, | Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
| 8744- | MeSA, | Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells |
| - | in-vitro, | Pca, | DU145 |
| 8758- | MeSA, | Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential |
| - | vitro+vivo, | RCC, | 786-O | - | in-vitro, | Kidney, | Caki-1 |
| 2456- | MET, | Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
| 2384- | MET, | Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication |
| - | in-vitro, | Thyroid, | BCPAP | - | in-vivo, | NA, | NA | - | in-vitro, | Thyroid, | TPC-1 |
| 2379- | MET, | Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | in-vitro, | BC, | UMUC3 |
| 5532- | MF, | Magnetoporation: New Method for Permeabilization of Cancerous Cells to Hydrophilic Drugs |
| - | in-vivo, | BC, | NA |
| 2255- | MF, | Pulsed Electromagnetic Fields Induce Skeletal Muscle Cell Repair by Sustaining the Expression of Proteins Involved in the Response to Cellular Damage and Oxidative Stress |
| - | in-vitro, | Nor, | SkMC |
| 2261- | MF, | Tumor-specific inhibition with magnetic field |
| - | in-vitro, | Nor, | GP-293 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 2260- | MF, | Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 | - | in-vivo, | NA, | NA |
| 8489- | MF, | Pulsed electromagnetic fields induce ferroptosis in osteosarcoma cells and promote osteogenic differentiation |
| - | in-vitro, | OS, | U2OS | - | in-vitro, | OS, | MG63 |
| 8486- | MF, | Silent forces, hidden currents: the influence of static magnetic field stimulation on tumor biophysics |
| - | Review, | Var, | NA |
| 3464- | MF, | Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology |
| - | Review, | Var, | NA |
| 3466- | MF, | The effect of magnetic fields on tumor occurrence and progression: Recent advances |
| - | Review, | Var, | NA |
| 7390- | MF, | A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP |
| 7387- | MF, | Effects of Sinusoidal Magnetic Field Observed on Cell Proliferation, Ion Concentration, and Osmolarity in Two Human Cancer Cell Lines |
| - | in-vitro, | AML, | HL-60 | - | in-vitro, | adrenal, | SK-HEP-1 |
| 526- | MF, | Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | HeLa | - | vitro+vivo, | Melanoma, | B16-BL6 | - | in-vitro, | Nor, | HEK293 |
| 538- | MF, | The extremely low frequency electromagnetic stimulation selective for cancer cells elicits growth arrest through a metabolic shift |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Melanoma, | MSTO-211H |
| 495- | MF, | How a High-Gradient Magnetic Field Could Affect Cell Life |
| - | in-vitro, | Cerv, | HeLa |
| 497- | MF, | In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells |
| - | vitro+vivo, | BC, | MCF7 | - | vitro+vivo, | Lung, | A549 |
| 502- | MF, | Electromagnetic field investigation on different cancer cell lines |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Colon, | SW480 | - | in-vitro, | CRC, | HCT116 |
| 504- | MF, | Effect of Magnetic Fields on Tumor Growth and Viability |
| - | in-vivo, | Var, | NA |
| 507- | MF, | Effects of extremely low frequency electromagnetic fields on the tumor cell inhibition and the possible mechanism |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | GP-293 |
| 513- | MF, | Exposure to a specific time-varying electromagnetic field inhibits cell proliferation via cAMP and ERK signaling in cancer cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | BC, | MCF7 | - | in-vivo, | Pca, | HeLa |
| 517- | MF, | Rad, | Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis |
| - | in-vivo, | BC, | MDA-MB-231 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:323 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid